In patients with metastatic colorectal cancer, second-line combination therapy, with oxaliplatin and fluorouracil-leucovorin, is superior to treatment with leucovorin, find researchers in the June issue of the Journal of Clinical Oncology.

Higher serum selenium levels may be associated with a reduced risk of esophageal adenocarcinoma in patients with Barrett's esophagus, find researchers in the latest issue of the Journal of the National Cancer Institute.

Eradication treatment allows resolution of symptoms in a large number of patients with dyspepsia, and reduces the endoscopic workload, find researchers in this week's issue of the British Medical Journal.